You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Stage III (unresectable)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial in Tampa, Chapel Hill, Durham (Thoracic Radiotherapy, Platinum Based Chemotherapy, Ipilimumab)

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Thoracic Radiotherapy
  • +3 more
  • Tampa, Florida
  • +2 more
Sep 30, 2022

NSCLC Trial in Changsha (Sugemalimab and Chemotherapy)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Sugemalimab and Chemotherapy
  • Changsha, China
    Hunan Cancer Hospital
Jul 7, 2023

Lung Cancer, Nonsmall Cell, Lung Cancer Stage III Trial (combination product, drug, procedure, radiation)

Not yet recruiting
  • Lung Cancer, Nonsmall Cell
  • Lung Cancer Stage III
  • Nivolumab and Chemotherapy
  • +3 more
  • (no location specified)
Aug 15, 2023

NSCLC Trial (Atezolizumab, Tiragolumab)

Not yet recruiting
  • NSCLC
  • (no location specified)
Apr 5, 2023

Omitting Clinical Target Volume in Radical Treatment of

Not yet recruiting
  • Immunotherapy
  • +3 more
  • IMRT+adjuvant immunotherapy
  • (no location specified)
Jun 9, 2023

NSCLC, Stage III Trial in Beijing (Tislelizumab, Pemetrexed (Nonsquamous NSCLC) or Paclitaxel/Nab-paclitaxel(Squamous NSCLC),

Recruiting
  • NSCLC, Stage III
  • Beijing, Beijing, China
    Beijing Tsinghua Chang Gung Hospital
Nov 4, 2022

Advanced Melanoma Trial in Beijing (JS001+Imatinib mesylate)

Recruiting
  • Advanced Melanoma
  • JS001+Imatinib mesylate
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Mar 2, 2022

Clinical Stage III Cutaneous Melanoma AJCC v8, Stage IV Melanoma, Unresectable Stage III Cutaneous Melanoma Trial in Boston

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +3 more
  • Boston, Massachusetts
  • +2 more
Sep 17, 2022

NSCLC Stage III, KRAS P.G12C Trial in Spain (Sotorasib)

Recruiting
  • Non-small Cell Lung Cancer Stage III
  • KRAS P.G12C
  • Badalona, Barcelona, Spain
  • +19 more
Jul 6, 2022

NSCLC, Stage III Trial in Pavia (Durvalumab)

Recruiting
  • NSCLC, Stage III
  • Pavia, Italy
    Fondazione IRCCS Policlinico San Matteo
Nov 9, 2021

Unresectable Melanoma, Metastatic Melanoma, Stage III NSCLC Trial in Louisville, New York (IOV-4001)

Recruiting
  • Unresectable Melanoma
  • +3 more
  • IOV-4001
  • Louisville, Kentucky
  • +2 more
Nov 21, 2022

Melanoma, Skin Cancer Trial in Tampa (Panobinostat, Ipilimumab)

Completed
Has Results
  • Melanoma
  • Skin Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 18, 2023

Melanoma Stage III, Melanoma Stage IV Trial in San Francisco (Binimetinib, Imatinib)

Recruiting
  • Melanoma Stage III
  • Melanoma Stage IV
  • San Francisco, California
    University of California, San Francisco
Dec 6, 2022

Omitting Clinical Target Volume of Unresectable Stage III

Completed
  • Stage III Non-small-cell Lung Cancer
  • The enrollment was randomly (1:1) assigned into the study group with CTV-omitted IMRT under PET-CT guidance and the control group with CTV-delineated IMRT using a random number table.
  • (no location specified)
Aug 29, 2022

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma, Ovarian Endometrioid Adenocarcinoma

Recruiting
  • Fallopian Tube Endometrioid Adenocarcinoma
  • +17 more
  • Biopsy
  • +3 more
  • Augusta, Georgia
  • +4 more
Jan 25, 2023

Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7 Trial in Rochester (drug,

Active, not recruiting
  • Metastatic Melanoma
  • +6 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 13, 2023

NSCLC Trial in Salvador, Belo Horizonte, São Paulo

Recruiting
  • Carcinoma, Non-Small-Cell Lung
    • Salvador, Bahia, Brazil
    • +3 more
    Nov 28, 2022

    Nonsmall Cell Lung Cancer Stage III, Unresectable Non-Small Cell Lung Carcinoma Trial in Winston-Salem (drug, other, diagnostic

    Not yet recruiting
    • Nonsmall Cell Lung Cancer Stage III
    • Unresectable Non-Small Cell Lung Carcinoma
    • Winston-Salem, North Carolina
      Wake Forest Baptist Comprehensive Cancer Center
    Jan 12, 2023

    Stage III Pancreatic Cancer American Joint Committee on Cancer (AJCC) v8, Stage IV Pancreatic Cancer AJCC v8, Unresectable

    Recruiting
    • Stage III Pancreatic Cancer American Joint Committee on Cancer (AJCC) v8
    • +2 more
    • Best Practice
    • +5 more
    • Los Angeles, California
      UCLA / Jonsson Comprehensive Cancer Center
    Oct 13, 2023

    Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma Trial

    Not yet recruiting
    • Advanced Esophageal Adenocarcinoma
    • +14 more
    • (no location specified)
    Jan 3, 2023

    Unresectable Non-Small Cell Lung Cancer (Stage III) in Canada

    Completed
    • Non-small Cell Lung Cancer
    • Calgary, Alberta, Canada
    • +4 more
    Jun 28, 2023

    Thymoma, Thymic Cancer Trial in Houston (Pembrolizumab)

    Recruiting
    • Stage III Thymoma AJCC v8
    • +6 more
    • Pembrolizumab
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 11, 2022

    Response to Chemoradiation and Durvalumab in Stage III NSCLC.

    Recruiting
    • Lung Cancer
    • Lung Cancer Stage III
    • Pavia, Italy
      Fondazione IRCCS Policlinico San Matteo
    Oct 25, 2021

    Melanoma, Unresectable Melanoma Trial in Los Angeles, Boston, New York (Sarilumab, Ipilimumab Injection, Nivolumab/Relatlimab)

    Not yet recruiting
    • Melanoma
    • Unresectable Melanoma
    • Los Angeles, California
    • +3 more
    Aug 4, 2022

    Melanoma Trial in Tampa (XL888, Vemurafenib)

    Active, not recruiting
    • Melanoma
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Aug 18, 2022